UniProt ID | ORC2_HUMAN | |
---|---|---|
UniProt AC | Q13416 | |
Protein Name | Origin recognition complex subunit 2 | |
Gene Name | ORC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 577 | |
Subcellular Localization | Nucleus. | |
Protein Description | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting it from ubiquitin-mediated proteasomal degradation. Also stabilizes ORC3.. | |
Protein Sequence | MSKPELKEDKMLEVHFVGDDDVLNHILDREGGAKLKKERAQLLVNPKKIIKKPEYDLEEDDQEVLKDQNYVEIMGRDVQESLKNGSATGGGNKVYSFQNRKHSEKMAKLASELAKTPQKSVSFSLKNDPEITINVPQSSKGHSASDKVQPKNNDKSEFLSTAPRSLRKRLIVPRSHSDSESEYSASNSEDDEGVAQEHEEDTNAVIFSQKIQAQNRVVSAPVGKETPSKRMKRDKTSDLVEEYFEAHSSSKVLTSDRTLQKLKRAKLDQQTLRNLLSKVSPSFSAELKQLNQQYEKLFHKWMLQLHLGFNIVLYGLGSKRDLLERFRTTMLQDSIHVVINGFFPGISVKSVLNSITEEVLDHMGTFRSILDQLDWIVNKFKEDSSLELFLLIHNLDSQMLRGEKSQQIIGQLSSLHNIYLIASIDHLNAPLMWDHAKQSLFNWLWYETTTYSPYTEETSYENSLLVKQSGSLPLSSLTHVLRSLTPNARGIFRLLIKYQLDNQDNPSYIGLSFQDFYQQCREAFLVNSDLTLRAQLTEFRDHKLIRTKKGTDGVEYLLIPVDNGTLTDFLEKEEEEA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Acetylation | AQLLVNPKKIIKKPE HHHHCCHHHHHCCCC | 51.94 | 25953088 | |
55 | Phosphorylation | KIIKKPEYDLEEDDQ HHHCCCCCCCCCCCH | 34.06 | 27642862 | |
70 | Phosphorylation | EVLKDQNYVEIMGRD HHHHCCCCEEECCCC | 8.20 | 28796482 | |
81 | Phosphorylation | MGRDVQESLKNGSAT CCCCHHHHHHCCCCC | 27.79 | 27134283 | |
93 | Acetylation | SATGGGNKVYSFQNR CCCCCCCCEEEECCH | 45.91 | 26051181 | |
95 | Phosphorylation | TGGGNKVYSFQNRKH CCCCCCEEEECCHHH | 12.84 | 23186163 | |
96 | Phosphorylation | GGGNKVYSFQNRKHS CCCCCEEEECCHHHH | 24.28 | 23917254 | |
103 | Phosphorylation | SFQNRKHSEKMAKLA EECCHHHHHHHHHHH | 41.78 | 23882029 | |
108 | Acetylation | KHSEKMAKLASELAK HHHHHHHHHHHHHHC | 40.88 | 25953088 | |
111 | O-linked_Glycosylation | EKMAKLASELAKTPQ HHHHHHHHHHHCCCC | 43.51 | 30379171 | |
111 | Phosphorylation | EKMAKLASELAKTPQ HHHHHHHHHHHCCCC | 43.51 | 30266825 | |
116 | Phosphorylation | LASELAKTPQKSVSF HHHHHHCCCCCCCEE | 25.91 | 23927012 | |
119 | Acetylation | ELAKTPQKSVSFSLK HHHCCCCCCCEEECC | 54.77 | 25953088 | |
120 | Phosphorylation | LAKTPQKSVSFSLKN HHCCCCCCCEEECCC | 20.11 | 26074081 | |
122 | Phosphorylation | KTPQKSVSFSLKNDP CCCCCCCEEECCCCC | 19.06 | 23401153 | |
124 | Phosphorylation | PQKSVSFSLKNDPEI CCCCCEEECCCCCCE | 30.81 | 29978859 | |
126 | Sumoylation | KSVSFSLKNDPEITI CCCEEECCCCCCEEE | 59.09 | - | |
132 | Phosphorylation | LKNDPEITINVPQSS CCCCCCEEEECCCCC | 12.58 | 26434776 | |
138 | Phosphorylation | ITINVPQSSKGHSAS EEEECCCCCCCCCCC | 28.13 | 25159151 | |
139 | Phosphorylation | TINVPQSSKGHSASD EEECCCCCCCCCCCC | 37.09 | 21815630 | |
147 | Acetylation | KGHSASDKVQPKNND CCCCCCCCCCCCCCC | 40.03 | 23749302 | |
155 | Ubiquitination | VQPKNNDKSEFLSTA CCCCCCCHHHHHHCC | 54.75 | - | |
156 | Phosphorylation | QPKNNDKSEFLSTAP CCCCCCHHHHHHCCC | 36.12 | 28555341 | |
160 | Phosphorylation | NDKSEFLSTAPRSLR CCHHHHHHCCCHHHH | 28.04 | 21712546 | |
161 | Phosphorylation | DKSEFLSTAPRSLRK CHHHHHHCCCHHHHH | 42.71 | 21712546 | |
165 | Phosphorylation | FLSTAPRSLRKRLIV HHHCCCHHHHHCEEE | 31.31 | 25056879 | |
175 | Phosphorylation | KRLIVPRSHSDSESE HCEEECCCCCCCCCC | 22.67 | 17081983 | |
177 | Phosphorylation | LIVPRSHSDSESEYS EEECCCCCCCCCCCC | 44.04 | 17081983 | |
179 | Phosphorylation | VPRSHSDSESEYSAS ECCCCCCCCCCCCCC | 46.14 | 17081983 | |
181 | Phosphorylation | RSHSDSESEYSASNS CCCCCCCCCCCCCCC | 45.87 | 17081983 | |
183 | Phosphorylation | HSDSESEYSASNSED CCCCCCCCCCCCCCC | 20.86 | 24461736 | |
184 | Phosphorylation | SDSESEYSASNSEDD CCCCCCCCCCCCCCC | 22.59 | 24461736 | |
186 | Phosphorylation | SESEYSASNSEDDEG CCCCCCCCCCCCCCC | 34.64 | 24461736 | |
188 | Phosphorylation | SEYSASNSEDDEGVA CCCCCCCCCCCCCCC | 39.65 | 21947279 | |
202 | Phosphorylation | AQEHEEDTNAVIFSQ CHHHHCCCCEEEEEH | 28.49 | 17081983 | |
208 | Phosphorylation | DTNAVIFSQKIQAQN CCCEEEEEHHHHHCC | 21.31 | 17081983 | |
219 | Phosphorylation | QAQNRVVSAPVGKET HHCCCEEECCCCCCC | 24.81 | 30266825 | |
226 | Phosphorylation | SAPVGKETPSKRMKR ECCCCCCCCCHHHCC | 36.03 | 29255136 | |
228 | Phosphorylation | PVGKETPSKRMKRDK CCCCCCCCHHHCCCC | 40.07 | 30266825 | |
235 | Ubiquitination | SKRMKRDKTSDLVEE CHHHCCCCCHHHHHH | 54.70 | - | |
236 | Phosphorylation | KRMKRDKTSDLVEEY HHHCCCCCHHHHHHH | 31.59 | 21712546 | |
237 | Phosphorylation | RMKRDKTSDLVEEYF HHCCCCCHHHHHHHH | 34.39 | 25159151 | |
243 | Phosphorylation | TSDLVEEYFEAHSSS CHHHHHHHHHHHCCC | 8.00 | 28796482 | |
248 | Phosphorylation | EEYFEAHSSSKVLTS HHHHHHHCCCCCCCC | 43.27 | 25159151 | |
249 | Phosphorylation | EYFEAHSSSKVLTSD HHHHHHCCCCCCCCH | 25.06 | 24732914 | |
250 | Phosphorylation | YFEAHSSSKVLTSDR HHHHHCCCCCCCCHH | 29.78 | 24732914 | |
251 | Ubiquitination | FEAHSSSKVLTSDRT HHHHCCCCCCCCHHH | 43.12 | - | |
254 | Phosphorylation | HSSSKVLTSDRTLQK HCCCCCCCCHHHHHH | 31.41 | 23186163 | |
255 | Phosphorylation | SSSKVLTSDRTLQKL CCCCCCCCHHHHHHH | 22.42 | 25159151 | |
258 | Phosphorylation | KVLTSDRTLQKLKRA CCCCCHHHHHHHHHH | 38.23 | 25159151 | |
266 | Ubiquitination | LQKLKRAKLDQQTLR HHHHHHHCCCHHHHH | 57.54 | - | |
266 | Acetylation | LQKLKRAKLDQQTLR HHHHHHHCCCHHHHH | 57.54 | 25953088 | |
277 | Phosphorylation | QTLRNLLSKVSPSFS HHHHHHHHHHCCCHH | 33.89 | 23312004 | |
278 | Ubiquitination | TLRNLLSKVSPSFSA HHHHHHHHHCCCHHH | 46.86 | - | |
278 | Acetylation | TLRNLLSKVSPSFSA HHHHHHHHHCCCHHH | 46.86 | 25953088 | |
280 | Phosphorylation | RNLLSKVSPSFSAEL HHHHHHHCCCHHHHH | 20.68 | 29255136 | |
282 | Phosphorylation | LLSKVSPSFSAELKQ HHHHHCCCHHHHHHH | 25.07 | 30266825 | |
284 | Phosphorylation | SKVSPSFSAELKQLN HHHCCCHHHHHHHHH | 25.77 | 30266825 | |
288 | Ubiquitination | PSFSAELKQLNQQYE CCHHHHHHHHHHHHH | 44.22 | - | |
475 | Phosphorylation | QSGSLPLSSLTHVLR ECCCCCHHHHHHHHH | 22.74 | - | |
483 | Phosphorylation | SLTHVLRSLTPNARG HHHHHHHHCCCCCHH | 32.22 | 22817900 | |
528 | Phosphorylation | REAFLVNSDLTLRAQ HHHHCCCCCCHHHHH | 26.90 | 20068231 | |
531 | Phosphorylation | FLVNSDLTLRAQLTE HCCCCCCHHHHHHHH | 21.13 | 20068231 | |
549 | Ubiquitination | HKLIRTKKGTDGVEY CCCEEECCCCCCCEE | 67.44 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ORC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ORC2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-116 AND SER-280, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-226, AND MASSSPECTROMETRY. |